FY2024 EPS Estimates for Bruker Co. Cut by Leerink Partnrs (NASDAQ:BRKR)

Bruker Co. (NASDAQ:BRKR) – Stock analysts at Leerink Partnrs reduced their FY2024 earnings estimates for Bruker in a research note issued on Tuesday, August 6th. Leerink Partnrs analyst P. Souda now forecasts that the medical research company will earn $2.61 per share for the year, down from their previous estimate of $2.66. The consensus estimate for Bruker’s current full-year earnings is $2.66 per share. Leerink Partnrs also issued estimates for Bruker’s Q1 2025 earnings at $0.58 EPS.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, meeting the consensus estimate of $0.52. Bruker had a net margin of 13.38% and a return on equity of 27.31%. The business had revenue of $800.70 million for the quarter, compared to the consensus estimate of $799.44 million. During the same period in the prior year, the company posted $0.50 earnings per share. Bruker’s revenue was up 17.4% compared to the same quarter last year.

A number of other brokerages also recently issued reports on BRKR. StockNews.com downgraded shares of Bruker from a “buy” rating to a “hold” rating in a research note on Tuesday, May 21st. Citigroup reduced their price objective on shares of Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, July 10th. Bank of America reduced their price objective on shares of Bruker from $95.00 to $90.00 and set a “buy” rating on the stock in a research note on Monday, May 20th. The Goldman Sachs Group reduced their price objective on shares of Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research note on Tuesday, July 9th. Finally, Stifel Nicolaus reduced their price target on shares of Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a research note on Monday, May 20th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $80.80.

Bruker Trading Down 2.1 %

Shares of Bruker stock opened at $62.00 on Friday. The company has a market capitalization of $9.01 billion, a price-to-earnings ratio of 22.55, a PEG ratio of 2.39 and a beta of 1.20. The company has a quick ratio of 0.91, a current ratio of 1.81 and a debt-to-equity ratio of 0.95. Bruker has a 12-month low of $53.79 and a 12-month high of $94.86. The firm’s 50-day moving average price is $64.22 and its two-hundred day moving average price is $75.60.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in BRKR. Norges Bank bought a new position in Bruker in the 4th quarter valued at approximately $74,582,000. TD Asset Management Inc raised its holdings in Bruker by 51.1% in the 4th quarter. TD Asset Management Inc now owns 1,664,779 shares of the medical research company’s stock valued at $122,328,000 after buying an additional 562,684 shares during the last quarter. Handelsbanken Fonder AB raised its holdings in Bruker by 2,342.1% in the 4th quarter. Handelsbanken Fonder AB now owns 388,300 shares of the medical research company’s stock valued at $28,532,000 after buying an additional 372,400 shares during the last quarter. Public Employees Retirement Association of Colorado raised its holdings in Bruker by 925.8% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 362,035 shares of the medical research company’s stock valued at $26,602,000 after buying an additional 326,741 shares during the last quarter. Finally, Epoch Investment Partners Inc. raised its holdings in Bruker by 248.4% in the 4th quarter. Epoch Investment Partners Inc. now owns 405,436 shares of the medical research company’s stock valued at $29,791,000 after buying an additional 289,055 shares during the last quarter. Institutional investors own 79.52% of the company’s stock.

Bruker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 17th. Investors of record on Monday, June 3rd were issued a $0.05 dividend. The ex-dividend date was Monday, June 3rd. This represents a $0.20 dividend on an annualized basis and a yield of 0.32%. Bruker’s dividend payout ratio (DPR) is presently 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.